ArticleScientific reports2026
Multi-model analysis of the combined toxic effects of ultrafine carbon black and amisulbrom on A549 Cells.
Article in Scientific reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Black carbon (BC), a typical nanoscale component of PM₂.₅, is environmentally persistent and prone to forming composite pollutants. Amisulbrom, a widely used pesticide, can migrate synergistically with atmospheric contaminants, yet their combined health risks remain unclear. This study evaluated the individual and combined toxicities of ultrafine carbon black (UFCB) and amisulbrom in A549 cells. Both agents induced dose-dependent cytotoxicity, with 24 h IC₅₀ values of 19.79 and 54.45 μg/mL, respectively. Multiple models including Bliss independence, weighted quantile sum, and Bayesian kernel machine regression consistently showed an additive effect rather than synergism or antagonism, with UFCB as the main contributor. Combined exposure significantly increased intracellular ROS and apoptosis, but glutathione and malondialdehyde showed no synergistic changes. Measured indicators were comparable to theoretical values, further verifying the additive joint effect.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.